Kai Sun, Chao Wang, Shanchun Gong, Xianjun Lyn, Kai Liu, Haidong Zhang, Zhenkun Yu
{"title":"Carotid Artery Reconstruction With Endovascular Covered Stents: An Innovative Strategy to Avoid Interruption of Carotid Blood Flow.","authors":"Kai Sun, Chao Wang, Shanchun Gong, Xianjun Lyn, Kai Liu, Haidong Zhang, Zhenkun Yu","doi":"10.1002/hed.28188","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Carotid artery reconstruction is the preferred approach for treating head and neck cancer involving carotid artery (HNC-CA). While current techniques often utilize various autologous or synthetic materials for reconstruction, they pose risks such as intraoperative carotid blood flow interruption and postoperative anastomotic thrombosis. Here, we report a carotid artery reconstruction based on endovascular covered stent (CAR-ECS), which uses an endovascular covered stent implantation (ECSI) technique that does not require intraoperative interruption of carotid blood flow and avoids vascular anastomotic maneuvers.</p><p><strong>Methods: </strong>Between June 2019 and December 2020, 18 patients with HNC-CA underwent the CAR-ECS surgery.</p><p><strong>Results: </strong>ECSI, tumor resection, and carotid artery reconstruction were successfully performed. There were no cases of carotid blowout syndrome, neurologic dysfunction, or perioperative death. Stenotic vessel internal diameter due to tumor invasion increased from 5.40 ± 1.31 mm to 7.32 ± 0.68 mm (p < 0.05). During a mean follow-up period of 11.7 months (range: 5-22 months), the 1-year overall survival rate was 61.31%, with a median survival time of 15.0 months (95% CI: 7.6-22.4). The locoregional recurrence rate was 33.3%, and the distant metastasis rate was 22.2%.</p><p><strong>Conclusions: </strong>In this study, we propose a novel carotid artery reconstruction and demonstrate the safety and reliability of CAR-ECS in reducing surgical risk and safeguarding patient prognosis.</p>","PeriodicalId":55072,"journal":{"name":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Head and Neck-Journal for the Sciences and Specialties of the Head and Neck","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/hed.28188","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Carotid artery reconstruction is the preferred approach for treating head and neck cancer involving carotid artery (HNC-CA). While current techniques often utilize various autologous or synthetic materials for reconstruction, they pose risks such as intraoperative carotid blood flow interruption and postoperative anastomotic thrombosis. Here, we report a carotid artery reconstruction based on endovascular covered stent (CAR-ECS), which uses an endovascular covered stent implantation (ECSI) technique that does not require intraoperative interruption of carotid blood flow and avoids vascular anastomotic maneuvers.
Methods: Between June 2019 and December 2020, 18 patients with HNC-CA underwent the CAR-ECS surgery.
Results: ECSI, tumor resection, and carotid artery reconstruction were successfully performed. There were no cases of carotid blowout syndrome, neurologic dysfunction, or perioperative death. Stenotic vessel internal diameter due to tumor invasion increased from 5.40 ± 1.31 mm to 7.32 ± 0.68 mm (p < 0.05). During a mean follow-up period of 11.7 months (range: 5-22 months), the 1-year overall survival rate was 61.31%, with a median survival time of 15.0 months (95% CI: 7.6-22.4). The locoregional recurrence rate was 33.3%, and the distant metastasis rate was 22.2%.
Conclusions: In this study, we propose a novel carotid artery reconstruction and demonstrate the safety and reliability of CAR-ECS in reducing surgical risk and safeguarding patient prognosis.
背景:颈动脉重建是治疗累及颈动脉的头颈癌(HNC-CA)的首选方法。虽然目前的技术通常使用各种自体或合成材料进行重建,但它们存在术中颈动脉血流中断和术后吻合口血栓形成等风险。在这里,我们报告了一种基于血管内覆盖支架(CAR-ECS)的颈动脉重建,它使用血管内覆盖支架植入术(ECSI)技术,不需要术中中断颈动脉血流,避免血管吻合口操作。方法:2019年6月至2020年12月,18例HNC-CA患者接受了CAR-ECS手术。结果:ECSI、肿瘤切除、颈动脉重建均成功。无颈动脉爆裂综合征、神经功能障碍或围手术期死亡病例。肿瘤侵袭后血管狭窄内径由5.40±1.31 mm增加到7.32±0.68 mm (p)。结论:本研究提出了一种新型颈动脉重建方法,证明了CAR-ECS在降低手术风险和保障患者预后方面的安全性和可靠性。
期刊介绍:
Head & Neck is an international multidisciplinary publication of original contributions concerning the diagnosis and management of diseases of the head and neck. This area involves the overlapping interests and expertise of several surgical and medical specialties, including general surgery, neurosurgery, otolaryngology, plastic surgery, oral surgery, dermatology, ophthalmology, pathology, radiotherapy, medical oncology, and the corresponding basic sciences.